Trial
NCT00582400
A Phase II Protocol of Arsenic Trioxide (Trisenox) in Subjects With Advanced Primary Carcinoma of the Liver
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
The University of Texas Medical Branch, Galveston
Collaborators
—
Condition
Carcinoma, Hepatocellular
Intervention
arsenic trioxide
Why stopped
recruiting or enrolling participants has halted prematurely and will not resume; participants are no longer being examined or treated
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-02-19